Medicare Enrolled

Dr. Joshua Jacobs, MD

Allergy & Immunology · Walnut Creek, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Speaking/Promotional
370 N WIGET LN STE 210, Walnut Creek, CA 94598
9259356252
In practice since 2005 (20 years)
NPI: 1215920673 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Jacobs from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Jacobs? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Jacobs

Dr. Joshua Jacobs is an allergy & immunology specialist in Walnut Creek, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Jacobs performed 42,601 Medicare services across 1,056 unique beneficiaries.

Between the years covered by Open Payments, Dr. Jacobs received a total of $1,455,095 from 57 pharmaceutical and/or device companies across 2377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in allergy & immunology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Jacobs is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 3% volume in CA $1,455,095 industry payments

Medicare Practice Summary

Medicare Utilization ↗
42,601
Medicare services
Top 3% in CA for allergy & immunology
1,056
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,130 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Tezepelumab injection, 1 mg
An injection of tezepelumab-ekko, a medication administered in 1 mg doses.
28,980 $14 $39
Omalizumab injection (Xolair) for asthma/allergy 7,650 $30 $60
Injection, benralizumab, 1 mg 1,890 $132 $248
Allergy skin test
A diagnostic test performed to identify specific allergies by applying or introducing allergenic extracts to the body. The procedure measures the patient's immune response to various potential allergens.
1,117 $4 $20
Allergy injection therapy, multiple injections
A professional service involving the administration of multiple allergen injections.
565 $11 $40
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
550 $14 $65
Allergy immunotherapy preparation
A professional service involving the preparation and administration of one or more antigens.
518 $13 $35
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
438 $107 $245
Health risk assessment administration and interpretation
This procedure involves administering a health risk assessment to a patient and interpreting the results.
175 $3 $25
Allergen injection administration
Professional service for the administration of a single allergen injection.
171 $9 $30
Nitric oxide gas level test
A test that measures the level of nitric oxide gas in the body.
120 $20 $55
Skin allergy test
A test where small amounts of potential allergens are injected into the skin to check for allergic reactions.
86 $8 $20
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
64 $28 $88
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
56 $57 $155
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
54 $55 $150
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
53 $39 $148
Ear wax removal
A procedure to remove impacted ear wax from the ear canal.
34 $41 $125
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
33 $143 $370
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
18 $77 $170
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
15 $37 $65
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
14 $72 $96
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,455,095
Total received (2018-2024)
Avg $207,871/year across 7 years
Top 0% in CA for allergy & immunology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
57
Companies
2,377
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,333,664 (91.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$110,230 (7.6%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,201 (0.8%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$248,422
2023
$246,052
2022
$222,307
2021
$117,754
2020
$119,759
2019
$314,248
2018
$186,552

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$72,558
GENZYME CORPORATION
$28,306
CSL Behring
$27,405
Takeda Pharmaceuticals U.S.A., Inc.
$26,792
Regeneron Healthcare Solutions, Inc.
$25,491
Blueprint Medicines Corporation
$20,494
Genentech USA, Inc.
$12,684
BioCryst US Sales Co., LLC
$10,200
Grifols USA, LLC
$9,159
GlaxoSmithKline, LLC.
$7,409
ADMA BioManufacturing LLC
$3,341
BioCryst Pharmaceuticals, Inc.
$1,871
Consortium of Independent Immunology Clinics, LLC
$900
Pharming Healthcare, Inc.
$695
Amgen Inc.
$527
kaleo, Inc.
$120
Octapharma USA, Inc.
$107
ABBVIE INC.
$83
LEO Pharma Inc.
$44
Greer Laboratories, Inc.
$42
Novartis Pharmaceuticals Corporation
$42
Lilly USA, LLC
$39
PFIZER INC.
$38
Cycle Pharmaceuticals Inc
$25
Kedrion Biopharma, Inc.
$21
Incyte Corporation
$17
Optinose US, Inc.
$14
Top 3 companies account for 51.6% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$292,796
Shire North American Group Inc
$196,963
Teva Pharmaceuticals USA, Inc.
$166,704
Regeneron Healthcare Solutions, Inc.
$145,637
GENZYME CORPORATION
$129,021
Takeda Pharmaceuticals U.S.A., Inc.
$115,874
CSL Behring
$79,589
Blueprint Medicines Corporation
$67,694
GlaxoSmithKline, LLC.
$58,136
BioCryst US Sales Co., LLC
$50,012
Grifols USA, LLC
$32,759
Amgen Inc.
$19,767
Genentech USA, Inc.
$16,894
Pharming Healthcare, Inc.
$15,361
Regeneron Pharmaceuticals, Inc.
$10,415
Hikma Pharmaceuticals USA
$7,400
AIMMUNE THERAPEUTICS, INC.
$7,234
Genentech, Inc.
$6,499
Fresenius Kabi USA, LLC
$5,648
BioCryst Pharmaceuticals, Inc.
$5,301
PFIZER INC.
$4,222
Novartis Pharmaceuticals Corporation
$4,203
ADMA BioManufacturing LLC
$3,371
Octapharma USA, Inc.
$2,905
OptiNose US, Inc.
$2,620
Acerta Pharma LLC
$1,975
ALK-Abello, Inc
$1,501
Consortium of Independent Immunology Clinics, LLC
$900
CYCLE PHARMACEUTICALS INC
$836
Boehringer Ingelheim Pharmaceuticals, Inc.
$518
kaleo, Inc.
$331
BioMarin Pharmaceutical Inc.
$298
Optinose US, Inc.
$248
ABBVIE INC.
$237
SANOFI-AVENTIS U.S. LLC
$187
Kaleo, Inc.
$162
Horizon Therapeutics plc
$105
Covis Pharma B.V.
$97
Circassia Pharmaceuticals Inc
$84
TerSera Therapeutics LLC
$75
Covis Pharma GmBH
$71
Greer Laboratories, Inc.
$67
LEO Pharma Inc.
$44
Grifols Shared Services North America, Inc.
$40
Lilly USA, LLC
$39
Bio Products Laboratory USA, Inc.
$34
Dermavant Sciences, Inc.
$31
Covis Pharma GmbH
$27
Cycle Pharmaceuticals Inc
$25
Kedrion Biopharma, Inc.
$21
QOL Medical, LLC
$20
Aimmune Therapeutics, Inc.
$20
Incyte Corporation
$17
Phadia US Inc.
$17
Eyevance Pharmaceuticals LLC
$16
Sanofi Pasteur Inc.
$15
Mylan Specialty L.P.
$11
Top 3 companies account for 45.1% of all-time payments
Associated products mentioned in payments ›
ACTIMMUNE · ADBRY · AIRSUPRA · ALVESCO · ANORO ELLIPTA · AREXVY · AUVI-Q · AYVAKIT · AirDuo Digihaler · AirDuo RespiClick · Albuked · Auvi-Q · BREO · BREZTRI · BREZTRI AEROSPHERE · CIBINQO · CINQAIR · CINRYZE · CUTAQUIG · CUVITRU · DUPIXENT · DUPIXENT DUPILUMAB INJECTION · Dymista · EBGLYSS · EUCRISA · FARXIGA · FASENRA · FEVIPIPRANT · FIRAZYR · FLUZONE HIGH-DOSE · Gammaplex · Gamunex-C · Grastek · HYQVIA · Haegarda · Hizentra · ILARIS · ImmunoCAP · Kcentra · NIOX VERO · NIOX VERO DEVICE · NITYR · NUCALA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPZELURA · ORALAIR · ORLADEYO · Odactra · Orladeyo · PALFORZIA · PANZYGA · PAXLOVID · PH-Icatibant · PRE-PEN · PROAIR · ProAir Digihaler · Prolastin-C Liquid · QVAR · Quzyttir · RINVOQ · RUCONEST · Ryaltris · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SYMBICORT · Sajazir · Sucraid · TAKHZYRO · TEZSPIRE · TRELEGY ELLIPTA · Tobradex ST · VTAMA · XOLAIR · Xembify · Xhance · Xolair
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in allergy & immunology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 0% for allergy & immunology in CA.

Looking for an allergy & immunology specialist in Walnut Creek?
Compare allergy & immunologists in the Walnut Creek area by procedure volume, costs, and industry payment transparency.
Browse allergy & immunologists nearby

Geographic Context

Allergy & immunologists within 10 mi
44
Per 100K population
3.8
County median income
$125,727
Nearest hospital
JOHN MUIR MEDICAL CENTER - WALNUT CREEK CAMPUS
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Jacobs is a mixed practice specialist, with above-average Medicare volume (top 3% in CA), with speaking/promotional industry engagement in the top 0% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Jacobs experienced with tezepelumab injection, 1 mg?
Based on Medicare claims data, Dr. Jacobs performed 28,980 tezepelumab injection, 1 mg services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Jacobs receive payments from pharmaceutical companies?
Yes. Dr. Jacobs received a total of $1,455,095 from 57 companies across 2,377 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Jacobs's costs compare to other allergy & immunologists in Walnut Creek?
Dr. Jacobs's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Jacobs) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →